Home › Funds › Gleason Group, Inc. › GILD

Gleason Group, Inc. position in GILD

GILEAD SCIENCES INC · Health Care

Gleason Group, Inc. reported holding 9,469 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 0.12% of its reported portfolio and ranking #38 among its reported holdings. Gleason Group, Inc. has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)9.47K sh
Reported value held$1.41M
Portfolio Weight0.12%
First reportedQ3 2023
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Gleason Group, Inc.'s GILD position evolved

Gleason Group, Inc. first disclosed a stake in GILD in Q3 2023 at 8,542 shares (US$640K). The position peaked in Q3 2026 at 9,469 shares, worth US$1.4M. Across 13 filings, Gleason Group, Inc. increased the stake 11 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 9,469 shares valued at US$1.4M — an increase of 51 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 8.54K $640.17K New
Q4 2023 8.62K $698.47K Add
Q1 2024 8.71K $638.26K Add
Q2 2024 8.89K $609.73K Add
Q3 2024 8.89K $745.48K Hold
Q4 2024 8.96K $828.05K Add
Q1 2025 9.03K $1.01M Add
Q2 2025 9.10K $1.01M Add
Q3 2025 9.16K $1.02M Add
Q4 2025 9.22K $1.13M Add
Q1 2026 9.27K $1.29M Add
Q2 2026 9.42K $1.19M Add
Q3 2026 9.47K $1.41M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Gleason Group, Inc. held GILD?

Gleason Group, Inc. has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Gleason Group, Inc.'s current position in GILD?

As of Q3 2026, Gleason Group, Inc. holds 9.47K shares of GILD (GILEAD SCIENCES INC), valued at $1.41M, representing 0.12% of its reported portfolio and ranking #38.

Has Gleason Group, Inc. been buying or selling GILD?

In the latest 13F filing (Q3 2026), Gleason Group, Inc. increased its position in GILD. The position peaked in Q3 2026 at 9.47K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.